| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,330,162 | 2,202,822 | 1,208,422 | 1,056,038 | 2,380,885 |
| Cost of Revenue
|
-1,905,891 | -1,262,273 | -969,535 | -917,936 | -1,621,860 |
|
Gross Profit
|
2,424,271 | 940,549 | 238,887 | 138,102 | 759,025 |
| Selling, General and Administrative Expenses
|
-266,810 | -160,730 | -130,247 | -126,229 | -154,803 |
|
Research and Development Expenses
|
-231,307 | -271,715 | -220,434 | -292,007 | -268,819 |
|
Operating Income/Expenses
|
-498,117 | -432,445 | -350,681 | -418,236 | -423,622 |
|
Total Operating Profit/Loss
|
1,926,154 | 508,104 | -111,794 | -280,134 | 335,403 |
| Total Net Finance Income/Expense
|
28,282 | 26,242 | 20,679 | 15,511 | 5,553 |
| Irregular Income/Expenses
|
1,765 | 0 | 2 | 1,114 | -1,420 |
|
Other Income/Expense, Non-Operating
|
30,368 | -9,419 | 22,951 | -965 | 38,853 |
|
Non-Operating Income/Expenses, Total
|
60,415 | 16,823 | 43,632 | 15,660 | 42,986 |
|
Pretax Income
|
1,986,569 | 524,927 | -68,162 | -264,474 | 378,389 |
|
Provision for Income Tax
|
-388,835 | -96,526 | 13,632 | 52,969 | -48,853 |
|
Net Income from Continuing Operations
|
1,597,734 | 428,401 | -54,530 | -211,505 | 329,536 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,597,734 | 428,401 | -54,530 | -211,505 | 329,536 |
|
Net Income after Non-Controlling/Minority Interests
|
1,597,734 | 428,401 | -54,530 | -211,505 | 329,536 |
|
Net Income Available to Common Stockholders
|
1,597,734 | 428,401 | -54,530 | -211,505 | 329,536 |
|
Diluted Net Income Available to Common Stockholders
|
1,597,734 | 428,401 | -54,530 | -211,505 | 329,536 |
| Basic EPS
|
15.76 | 4.24 | -0.54 | -2.10 | 3.28 |
| Diluted EPS
|
15.69 | 4.21 | -0.54 | -2.10 | 3.26 |
|
Basic Weighted Average Shares Outstanding
|
101,515.81 | 101,124.69 | 101,666.03 | 100,716.67 | 100,412.64 |
|
Diluted Weighted Average Shares Outstanding
|
101,854.58 | 101,779.93 | 101,666.03 | 100,716.67 | 100,972.05 |
|
EBIT
|
1,958,287 | 498,685 | -88,841 | -279,985 | 372,836 |
|
EBITDA
|
2,254,439 | 808,023 | 302,528 | 177,366 | 850,262 |
|
Normalized EBITDA
|
2,306,312 | 844,911 | 323,060 | 207,033 | 908,962 |
|
Normalized Income
|
1,639,453.79 | 458,505.85 | -38,104.28 | -187,779.74 | 380,657.36 |
|
Total Unusual Items
|
51,873 | 36,888 | 20,532 | 29,667 | 58,700 |
|
Total Unusual Items Excluding Goodwill
|
51,873 | 36,888 | 20,532 | 29,667 | 58,700 |
|
Tax Effect of Unusual Items
|
10,153.21 | 6,783.15 | 4,106.28 | 5,941.74 | 7,578.64 |
|
Tax Rate, Calculated
|
0.20 | 0.18 | 0.20 | 0.20 | 0.13 |
12/31/2022 - 7/15/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade